NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financi... ('s second collaboration with a worldwide...)

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

Date:4/1/2009

's second collaboration with a worldwide market leader after our alliance with Alcon in the ophthalmic, otic and sinusitis fields. We expect to maintain a low cash burn in 2009 as we work closely with our partners that fund clinical development costs, and as we focus investment on developing our earlier-stage internal pipeline programs for which we anticipate proof-of-concept data later this year."

2008 and Recent Highlights

Ophthalmic: NovaBay continues to work closely with Alcon, Inc. to commercialize Aganocide compounds to treat infections of the eye, ear and sinus, and to develop the next generation of contact lens solutions. Alcon recently initiated a Phase I clinical trial of NVC-422 (N,N-dichloro-2,2-dimethyltaurine), NovaBay's lead Aganocide compound, after receiving clearance of an Investigational New Drug (IND) application from the U.S. Food and Drug Administration in January 2009. The IND clearance triggered an immediate milestone payment of $1 million from Alcon to NovaBay.

Dermatology: In March 2009, NovaBay announced a global agreement with Galderma, S.A. to develop and commercialize Aganocides for large dermatological markets such as acne, impetigo and other conditions. Under the terms of the agreement, NovaBay expects to receive from Galderma up to $50 million upon achievement of certain development and regulatory milestones related to the acne and impetigo indications and escalating double digit royalties on future net sales of products. Galderma will be responsible for the development costs of the acne and other indications, except in Japan, and for the ongoing development program for impetigo, upon the achievement of a specified milestone. NovaBay also announced in March new data presented at the American Academy of Dermatology 67th Annual Meeting that showed NVC-422 achieved significant clinical and myco
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:12/16/2009)... 22% for fiscal 2009; on track for positive ... 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) a ... today reported financial results for fourth quarter and ... 30, 2009, Microbix reported revenues of $6.08 million, ... 2008. For fourth-quarter 2009, the Company saw revenues ...

(Date:12/16/2009)... LLC introduces HSP-A Soy Peptone. HSP A has been found ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( ... HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, ... to improve growth rates and yields. HSP-A has been found ...

(Date:12/15/2009)... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... ), a,leading fully integrated pharmaceutical company developing and ... ("PRC"), today,announced that the Company has 30 medicines ... the National Basic Medical Insurance, Industrial Injury Insurance,and ... The 30 medicines treat a variety of ...

(Date:12/15/2009)... PLYMOUTH, Minn., Dec. 15 The Mosaic Company (NYSE: ... quarter fiscal year 2010 earnings results and financial tables ... trading on the New York Stock Exchange. Results ... ,, The Company will host a conference call ... discuss the results. The call will begin at ...

Breaking Biology Technology:Microbix' Pipeline Set To Reach Milestones In 2010 2 Microbix' Pipeline Set To Reach Milestones In 2010 3 Microbix' Pipeline Set To Reach Milestones In 2010 4 Microbix' Pipeline Set To Reach Milestones In 2010 5 Microbix' Pipeline Set To Reach Milestones In 2010 6 Microbix' Pipeline Set To Reach Milestones In 2010 7 Microbix' Pipeline Set To Reach Milestones In 2010 8 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2 China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3 Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2

[0] Microbix' Pipeline Set To Reach Milestones In 2010 [0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call

... July 25 Beckman,Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical,testing, announced ... 30, 2008,results. Total revenue of $798.3 million increased ... was up 11.2%. Net earnings were,$47.8 million, or ...

... Mind Foundation and conducted by TNS Teleseker, revealed that a majority ... methods that could "put them into a creative state and keep ... ... Jerusalem, Israel (PRWEB) July 26, 2008 -- A recent ...

... and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX ... drugs for infectious,diseases, advises that the directors of ... (the "Meeting") to be held at 2:00 p.m. ... 2389 Health Sciences Mall, Vancouver,British Columbia. Further details ...

Beckman Coulter Announces Second Quarter 2008 Results Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science Notice of MIGENIX General Meeting of Shareholders

(Date:12/16/2009)... source of financial and technical assistance to developing countries ... appear to be connected to space technology, but large ... intrinsically linked. , Global climate change is also an ... in the poorest countries and communities, which will suffer ... led to a growing demand for information about the ...

(Date:12/16/2009)... than 4 billion years before humans showed up, and ... That suggests they may have something to teach us. ... Prof. Eshel Ben-Jacob of the Raymond and Beverly Sackler ... of bacteria, presents compelling evidence to suggest there may ... opt for the swine flu H1N1 shot. , In ...

(Date:12/16/2009)... SUNNYVALE, Calif., Dec. 1 GestureTek ... CUBE, Release 3.0 - a turnkey, portable, ... for advertising, exhibits, entertainment and touring promotions. ... dozens of patents in camera-enabled gesture recognition ... systems. ,, Guaranteed for quality, the CUBE ...

Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2 ESA and World Bank move toward closer collaboration 3 ESA and World Bank move toward closer collaboration 4 Bacteria wouldn't opt for a swine flu shot 2 Bacteria wouldn't opt for a swine flu shot 3 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2 GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 1 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 2 The Leukemia 26 Lymphoma Society and FORMA Therapeutics Enter Collaboration to Bring New Therapies to Patients Faster 52091 3 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 1 Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 2 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 1 Oncolytics Biotech 28R 29 Inc Completes Lyophilization Process for REOLYSIN 28R 29 13083 2

[0] ESA and World Bank move toward closer collaboration [0] Bacteria wouldn't opt for a swine flu shot [0] GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits

... marine biologists will gather in Auckland from 14-16 November to ... to the tropics. This major meeting of a global marine ... jointly hosted by the National Institute of Water & Atmospheric ... The Census of Marine Life is a ten-year initiative to ...

... confused feelings that occur when you meet someone whose ... his or her gender., A new study by neuroscientists ... processing of such sensory information about anothers gender to ... study concludes that it does, weighing in with findings ...

... There are many historical stories of shepherds and travellers ... of tales about attacks on flocks and people by ... of their former range, but for livestock owners around ... a daily reality. Although loss of human life is ...

Other Biology News:Hearing changes how we perceive gender 2 Hearing changes how we perceive gender 3 Hearing changes how we perceive gender 4 Living with lions 2

Scientists gather in New Zealand to share oceans' secrets Hearing changes how we perceive gender Living with lions

... Vesicular Monoamine Transporter 2 (VMAT2). An antibody ... a major band at ~55 kDa in ... and not in wild type cells (2). ... molecular weight, were also detected and remain ...

... INK4a-ARF locus encodes two unrelated proteins both ... arrests the cell cycle in a p53-dependent ... the rapid degradation of mdm2 proteinrequired for ... accumulation. This interaction is mediated by ...

... immunoblotting the antibody reacts against the reduced ... MMP-2 or MMP-2 bound to TIMP-2. affinity ... Solution in 0.01 M phosphate buffered ... 15 mM sodium azide. synthetic peptide corresponding ...

... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Mfr Desig: ...

Biology Products:

Anti-Vesicular Monoamine Transporter 2 (VMAT2) Polyclonal Antibody, Unconjugated from CHEMICON Mouse Anti-p14 ARF / p16Beta Ab-2 Mouse Monoclonal Antibody, Unconjugated, Clone 14P02 from Lab Vision Rabbit Anti-Matrix Metalloproteinase-2, Hinge Region Antibody, Unconjugated from Sigma-Aldrich Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financi...('s second collaboration with a worldwide...)